Published in
Springer, Breast Cancer Research and Treatment, 1(173), p. 123-133, 2018
DOI: 10.1007/s10549-018-4964-y
Links
Tools
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study
Journal article published in 2018 by
Hiroji Iwata 
,
Norikazu Masuda,
Yutaka Yamamoto,
Tomomi Fujisawa,
Tatsuya Toyama,
Masahiro Kashiwaba,
Shoichiro Ohtani,
Naruto Taira,
Takehiko Sakai,
Yoshie Hasegawa,
Rikiya Nakamura,
Hiromitsu Akabane,
Yukiko Shibahara,
Hironobu Sasano,
Takuhiro Yamaguchi
and other authors.
,
Norikazu Masuda,
Yutaka Yamamoto,
Tomomi Fujisawa,
Tatsuya Toyama,
Masahiro Kashiwaba,
Shoichiro Ohtani,
Naruto Taira,
Takehiko Sakai,
Yoshie Hasegawa,
Rikiya Nakamura,
Hiromitsu Akabane,
Yukiko Shibahara,
Hironobu Sasano,
Takuhiro Yamaguchi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 